🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Pandemic Recovery: What Should You Do With These 3 Stocks?

Published 2021-03-03, 12:15 p/m
Pandemic Recovery: What Should You Do With These 3 Stocks?

It finally looks like an end to the COVID-19 pandemic is in sight. Multiple vaccines have been released, with many countries well underway with distributing these vaccinations. Even with variants, we should see a massive shift in the next year. Yet it has many investors wondering if they should be dumping pandemic-related stocks.

I’ll look at three industries and discuss if you should hold on to these pandemic stocks once a recovery is completely underway.

E-commerce There was a massive boom in the e-commerce industry almost immediately after the pandemic hit. With everyone stuck at home, we needed items, and we wanted to stay safe. Obviously, this created a huge demand for companies that were able to meet the demand.

One such stock, of course, is Shopify (TSX:SHOP)(NYSE:SHOP). Shopify soared during the pandemic and continues to climb towards $2,000 per share with some dips recently. It beat analyst expectations again and again during the pandemic, but can this continue?

The answer is yes and no. On the one hand, the e-commerce industry was already expected to boom over the next decade. But it’s true that the pandemic sped things up. Shopify management admitted it’s unlikely to see such a strong year as it had in 2020. However, it does plan to see continued solid growth in its subscriptions and through its recurring revenue. Plus, the company always seem to have tricks up its sleeve on making more money.

So, for Shopify stock, if you own it, keep it. E-commerce will continue to boom. In fact, I’d argue it’s s still a solid buy if you have the funds, as shares trade about 11% below all-time highs as of writing.

Telehealth Telehealth stocks also saw a massive boost during the pandemic. Again, with everyone stuck at home but still needing medical services, telehealth became invaluable. But again, many wonder whether telehealth stocks will even be used when everything returns to normal.

In short, yes, they will. It’s unlikely that telehealth companies will suddenly become obsolete. If you used these services, and it’s likely you have, why would you go to see your doctor for a conversation you can have safely and conveniently at home? This brings down wait times, allowing doctors to see more patients. It also gives more experience to younger doctors as well as more opportunities for people to talk to healthcare professionals in rural areas.

Telehealth got a boost it wasn’t likely to have seen without a pandemic. Now, it’s a necessity. That goes for a company like WELL Health Technologies (TSX:WELL). The company continues to expand through acquisitions, most recently making a huge move into the United States. Yet the company is still cheap for investors looking to buy long term. If you’d bought a year ago, shares are already up 435% for this stock.

Software as a Service The Software-as-a-Service (SaaS) sector is similar to e-commerce. It already existed but got a major boost during the pandemic as everyone came online. Companies that provided these services received a boost practically across the board. Yet, again, many worry there will be a drop post-pandemic.

This one makes the least sense. Companies like Kinaxis (TSX:KXS) are stocks that will continue to grow revenue, pandemic or not, and this year proved it. Consumers needed to change their shopping behaviour, and Kinaxis was there to help companies manage this. The company provides supply chain management solutions around the world, with its cloud-based business seeing recurring revenue continue to grow year over year.

In fact, Kinaxis is up 55% this year but has a compound annual growth rate of 34% over the last five years. It consistently grows its sales and free cash flow, with no long-term debt on hand. There’s been a stock correction recently that could disappear when earnings come out on Mar. 4 with management’s earnings guidance.

The post Pandemic Recovery: What Should You Do With These 3 Stocks? appeared first on The Motley Fool Canada.

Fool contributor Amy Legate-Wolfe owns shares of WELL, KINAXIS INC, and Shopify. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends Shopify and Shopify. The Motley Fool recommends KINAXIS INC.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2021

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.